According to statistics, about 20% of dogs and cats over one-year-old suffer from various degrees of bone and joint problems, and the proportion increases with age, with the incidence rate reaching 80% after the age of eight, which shows that the market demand for pet joint health care is increasing. Noticing such a demand, ISCO has partnered with Lonza, the manufacturer of UC-II®, a non-denaturing type II collagen that stimulates autologous repair of the joint matrix to help promote joint health and is a revolutionary ingredient in the joint field. As a result,
the first pet joint health product with UC-II® in China, the “IN+Vet UC-II® capsule”, has been launched. (Source: 163.com)